Skip to content
Company Analysis

Envista Holdings Corporation NVST

A comprehensive view of key metrics, scores, and financial health for Envista Holdings Corporation

Overview of Envista Holdings Corporation

NVST NYQ
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Mid Cap
Envista Holdings Corporation (NVST), is a Mid Cap company, in the Medical Instruments & Supplies industry, last closed at $24.60, about 5.0% undervalued vs fair value, +33.3% 1Y return, placing in the top 25% of its sector.
Metrics Rev Growth 8.3% ROE 1.6% Gross Margin 54.7%
USD 24.60
0.41%
(Delayed)
• Vol 90d: 47.8%
52-Week Range
Market Cap
$3.92B
Enterprise Value
$4.30B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Weak
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Good
Valuation
Weak
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://envistaco.com
HQ Brea, CA
Employees 12,000
Fiscal year Dec 31

Next Events

Earnings Aug 5 Estimated

Fair Value Snapshot

Bear Base Bull
$23
$26
$29
Current: $24.60 +5% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$2.7B
8.3%%
Gross Profit
$1.5B
8.3%%
Operating Income (GAAP)
$235.8M
71.9%%
EBITDA
$364.5M
141.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
54.7%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
1/2
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Envista Holdings Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
63
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
62
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing NVST's balance between Growth (22.2%), Profitability (39.5%), and Safety (38.3%). Growth 22% Safety 38% Profitability 40%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

37th percentile vs peers
37
Key Signals
Rev Growth YoY 8.3% 56p Revenue CAGR 3Y 1.9% 35p Asset Growth YoY 6.1% 68p EPS Growth YoY -9.82 2p
Strengths
  • Cash Flow to Debt Ratio in top 20% of peers (1.35, 86th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Consistently strong margins across 3 metrics
Risks
  • EPS Growth YoY in bottom 20% of peers (-9.82)
  • Growth below peer median (percentile: 37)

Profitability

66th percentile vs peers
66
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

64th percentile vs peers
64
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Envista Holdings Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$25.83
- - -
+5.0% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000